Skip to main content

CITADEL ADVISORS LLC

Position in ALGS — Aligos Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in ALGS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$403,530
-$79,562 QoQ
Shares Held
54,311
+4.8% QoQ
Ownership
1.51%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALGS Over Time

Shares Held

Position Value (USD)

Derivatives in ALGS

reported options exposure · as of Jun 30, 2024
CallValue
$490
CallShares
56
PutValue
$105
PutShares
12

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ALGS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $403,530 54,311
2025-12-31 $483,092 51,834
2025-09-30 $101,037 10,310
2025-06-30 $109,577 15,198
2024-06-30 $97,077 277,363
2024-06-30 $105 300
2024-06-30 $490 1,400
2024-03-31 $196 200
2024-03-31 $3,724 3,800
2024-03-31 $279,964 285,679
2023-06-30 $4,563 4,700
2023-06-30 $27,050 27,859
2023-03-31 $11,012 12,600
2023-03-31 $76,803 87,877
2023-03-31 $87 100
2022-12-31 $6,766 7,100
2022-12-31 $82,222 86,278
2022-12-31 $95 100
2022-09-30 $80,623 73,295
2022-06-30 $192,315 158,939
2022-03-31 $34,400 16,000
2022-03-31 $48,021 22,336
2021-12-31 $190,109 16,016
2021-12-31 $182,798 15,400
2021-06-30 $333,396 16,355